Planta Med 2008; 74(4): 396-400
DOI: 10.1055/s-2008-1034329
Pharmacology
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

21-Methylmelianodiols from Poncirus trifoliata as Inhibitors of Interleukin-5 Bioactivity in Pro-B Cells

In Jeong Lee1 , Guang-Hua Xu2 , Jung-Hun Ju1 , Jeong Ah Kim2 , Soon-Woo Kwon1 , Seung Ho Lee2 , Sang-Bae Han1 , Youngsoo Kim1
  • 1College of Pharmacy & Research Center for Bioresource and Health, Chungbuk National University, Cheongju, Korea
  • 2College of Pharmacy, Yeungnam Univeristy, Kyeongsan, Korea
Further Information

Publication History

Received: January 23, 2008

Accepted: February 6, 2008

Publication Date:
26 March 2008 (online)

Preview

Abstract

Interleukin (IL)-5 plays an important role in the progression of allergic inflammation. Here, we have isolated 21α-methylmelianodiol and 21β-methylmelianodiol from Poncirus trifoliata (L.) Raf., a plant of the Rutaceae family, as the inhibitors of IL-5-dependent growth of Y16 pro-B cells by bioassay-guided fractionation. 21α-Methylmelianodiol and 21β-methylmelianodiol inhibited IL-5-dependent growth of Y16 cells in a dose-dependent manner with IC50 values of 17 μM and 15 μM, respectively. A positive control, tyrphostin AG-490, exhibited an IC50 value of 23 μM on IL-5 bioactivity. Further, we have documented that 21α-methylmelianodiol and 21β-methylmelianodiol cause G1 arrest of IL-5-induced cell cycle progression of Y16 cells, and also reduce IL-5-dependent survival of the cells by apoptosis. This study could provide a pharmacological potential for P. trifoliata in treatment of IL-5-associated inflammatory disorders.

References

Prof. Youngsoo Kim

College of Pharmacy

Chungbuk National University

Cheongju 361-763

Korea

Fax: +82-43-268-2732

Email: youngsoo@chungbuk.ac.kr